Clinical Trial Update: Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated two immunization schedules of the ALVAC-HIV vCP1452 vaccine in chronically HIV-infected patients, focusing on immunogenicity and sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ALVAC-HIV vCP1452

Snippet

Sponsor: Objectif Recherche Vaccins SIDA | Conditions: HIV Infection | Phase 2 | Status: COMPLETED